«Is a four-week hormone suspension necessary for thyroid remnant ablation in low and intermediate risk patients? A pilot study with quality-of-life assessment», Braz. J. Radiat. Sci., vol. 10, n.º 4, pp. 1–16, dic. 2022, doi: 10.15392/2319-0612.2022.2047.